Daily Reporter

Refine search

Date

Any time

This month

This year

Before this year

Tumour Site

Breast Cancer
Carcinoma of Unknown Primary Site (CUP)
Central Nervous System Malignancies
Endocrine Tumours
- Adrenal Carcinoma
- Neuroendocrine Neoplasms
- Thyroid Cancer
Gastrointestinal Cancers
- Anal Cancer
- Colon and Rectal Cancer
- Gastric Cancer
- Gastro-Oesophageal Junction Cancer
- Hepatobiliary Cancers
- Oesophageal Cancer
- Pancreatic Adenocarcinoma
Genitourinary Cancers
- Malignant Germ-Cell Tumours of the Adult Male
- Penile Cancer
- Prostate Cancer
- Renal Cell Cancer
- Urothelial Cancer
Gynaecological Malignancies
- Cervical Cancer
- Endometrial Cancer
- Gestational Trophoblastic Neoplasia
- Ovarian Cancer
- Vulvar and Vaginal Cancers
Haematological Malignancies
- Leukaemias
  - Acute Lymphoblastic Leukaemia
  - Acute Myeloid Leukaemia
  - Chronic Lymphocytic Leukaemia
  - Chronic Myeloid Leukaemia
  - Hairy Cell Leukaemia
- Lymphomas
  - Follicular Lymphoma
  - Hodgkin Lymphoma
  - Large B-Cell Lymphoma
  - Mantle Cell Lymphoma
  - Marginal Zone Lymphoma
  - Peripheral T-Cell Lymphoma
  - Primary Cutaneous Lymphoma
- MDS/MPN/Others
- Multiple Myeloma
Head and Neck Cancers
Sarcoma
- Bone Sarcomas
- GIST
- Soft Tissue Sarcomas
Skin Cancers
- Basal Cell and Squamous Cell Cancers of the Skin
- Melanoma
- Merkel Cell Carcinoma
Thoracic Malignancies
- Mesothelioma
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Thymoma and Thymic Cancer

Topics

Basic Science
- Cancer Biology
- Molecular Oncology
- Tumour Immunology
Cancer Control Principles
- Cancer Care Equity Principles and Health Economics
- Cancer Intelligence (eHealth, Telehealth Technology, BIG Data)
- Fundamentals of Cancer Care Organisation
- Global Cancer Control
- Multi-Disciplinary and Multi-Professional Cancer Care
Cancer Diagnostics
- Genetic and Genomic Testing
- Laboratory Diagnostics
- Pathology/Molecular Biology
Cancer Epidemiology
- Cancer Registries
- Global Cancer Statistics
Cancer in Special Situations/ Populations
- AIDS-Associated Malignancies
- Cancer and Pregnancy
- Cancer in Adolescents and Young Adults (AYA)
- Cancer in LGBTQ Populations
- Cancer in Older Adults
- Cancer Treatment in Patients with Comorbidities
- COVID-19 and Cancer
Cancer Prevention
- Population Risk Factor
- Primary Prevention
- Secondary Prevention/Screening
Cancer Research
- Bioethical Principles and GCP
- Clinical Research
- Statistics
- Translational Research
Career Development
Emergency in Oncology
Genetic Testing and Counselling
Psychosocial Aspects of Cancer
- Communication Skills
- Patient Education and Advocacy
- Psycho-Oncology
Rare Cancers
Staging and Imaging
- Nuclear Medicine and Clinical Molecular Imaging
- Radiological Imaging
- Response Evaluation (RECIST Criteria)
- Staging Procedures
Supportive and Palliative Care
- End-of-Life Care
- Management of Systemic Therapy Toxicities
- Nutritional Support
- Supportive Care and Symptom Management
Survivorship
Therapy
- Cell-Based Therapy
- Cytotoxic Therapy
- Endocrine Therapy
- Image-Guided Therapy
- Immunotherapy
- Radiation Oncology
- Surgical Oncology
- Targeted Therapy

Congress

All congresses
ESMO Congress 2023
ESMO Asia Congress 2023
ESMO Immuno-Oncology Congress 2023
ESMO Targeted Anticancer Therapies Congress 2024
ESMO Sarcoma and Rare Cancers Congress 2024
European Lung Cancer Congress 2024
ESMO Breast Cancer 2024
ESMO Gynaecological Cancers Congress 2024
ESMO Gastrointestinal Cancers Congress 2024
ESMO Congress 2024
Molecular Analysis for Precision Oncology Congress (MAP) 2024
Molecular Analysis for Precision Oncology Congress (MAP) 2023
ESMO Breast Cancer 2023
ESMO Sarcoma and Rare Cancers Congress 2023
European Lung Cancer Congress 2023
ESMO Targeted Anticancer Therapies Congress 2023
ESMO Gynaecological Cancers Congress 2023
ESMO Asia Congress 2022
ESMO Immuno-Oncology Congress 2022
Molecular Analysis for Precision Oncology Congress 2022
ESMO Congress 2022
ESMO Gynaecological Cancers Congress 2022
ESMO Breast Cancer 2022
European Lung Cancer Congress 2022
ESMO Targeted Anticancer Therapies Congress 2022

Clear all

All filters

678 results for ""

Sort by

Cancer in Special Situations/ Populations

Is COVID-19 turning back the clock for patient empowerment?

After years of progress in empowering patients with cancer to play a more active role in their care, the COVID-19 pandemic is leaving many feeling anxious with little control over if, when or how they will receive a diagnosis or treatment.

20 Oct 2020

Cancer Research

Increased bureaucracy downgrades efficiency in cancer research

Nearly 20 years since the first steps to harmonise clinical trial regulations across Europe, bureaucracy is now stifling research in oncology. A newly established ESMO Clinical Research Observatory (ECRO) Task Force identifies priorities for action.

20 Oct 2020

Cancer Research

Does academic research really need so much administrative work?

20 Oct 2020

Cancer in Special Situations/ Populations

It is time to extend the continuity of cancer care beyond hospital walls

General practitioners handle a lifetime of health concerns for their patients – so why exclude them from cancer management?

20 Oct 2020

Cancer Research

What would have been unthinkable before became feasible in the interest of patient safety

Temporary accommodations made to weather the COVID-19 pandemic could accelerate lasting reform of clinical trial methodology.

20 Oct 2020

Cancer in Special Situations/ Populations

Young oncologists in the coronavirus crisis: a learning opportunity

Despite some share the concern of having their career plans delayed or disrupted by the pandemic, the new challenges emerged in these unprecedented times represent a unique opportunity to grow-up as oncology professionals and get ready to a new scenario where team working, humanisation of care and virtual education will be more crucial than ever.

20 Oct 2020

Cancer Control Principles

Telemedicine: the good and bad of living a hype

New forms of remote cancer care services have been piloted since the COVID-19 outbreak to offer support to patients while complying with hospital visiting restrictions. Despite a renewed popularity of telemedicine, digital services implemented so quickly may increase the risk of unmet expectations in the future.

20 Oct 2020

Cancer in Special Situations/ Populations

Patients with cancer and research: will COVID-19 further damage opportunities to join experimental trials?

Patients are missing out on potentially lifesaving clinical trials, but the pandemic era could be the trigger for a much-needed change in practice, says Dr Bettina Ryll, Founder of the Melanoma Patient Network Europe.

20 Oct 2020

Cancer in Special Situations/ Populations

How to make the right therapeutic choice for cancer patients at a time of crisis

According to Prof. Alberto Sobrero the most effective anticancer treatment is not always the right choice, and safely reducing treatment doses and duration is worthwhile when considered in keeping with patient values.

20 Oct 2020

Present and Future of Cancer Immunotherapy

The current evidence suggests that a large proportion of patients not responding to PD-1/PD-L1-targeted agents do not have PD-L1-expressing tumours

12 Oct 2020

1
...
53
54
55
56
57
58 of 68
59
60
61
62
63
...
68